When will SANOFI.NS stock report earnings and what matters most?

SANOFI.NS stock reports Q4 results on 25 Feb 2026. Investors should focus on revenue growth, operating margin, export volumes and management guidance for FY27, as these items drive immediate share reaction.

How expensive is SANOFI.NS stock versus peers?

SANOFI.NS stock trades at PE **26.35**, above some domestic peers but below its 52-week high. Price-to-book at **12.02** signals premium valuation relative to balance sheet metrics.

What does Meyka AI forecast for SANOFI.NS stock?

Meyka AI's forecast model projects a yearly price of INR **5439.19**, implying a **33.31%** upside from the current INR **4080.70**. These projections are model-based and not guarantees.

What are the main risks for SANOFI.NS stock after earnings?

Main risks include weaker-than-expected margins, distributor destocking, regulatory changes and any cut to the dividend. High valuation metrics can amplify downside on a profit miss.

IN Stocks

Earnings due: Sanofi India (SANOFI.NS) NSE pre-market 25 Feb 2026: guidance is key

ByDanny Kontos February 25, 2026February 25, 2026

SANOFI.NS stock is in focus pre-market on 25 Feb 2026 as Sanofi India Limited (SANOFI.NS) reports Q4 results today. The company trades on the NSE in India at INR 4080.70 and carries a price-to-earnings of 26.35 based on the latest quote. Investors will watch revenue, margin trends and management guidance closely, since the market often re-prices healthcare names on forward guidance. Sanofi India’s EPS is 154.89 and the company pays a high dividend per share of 192.00 INR, both key inputs for near-term moves.